This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, G. N. Articles by Buckley, L. A. Search for Related Content PubMed PubMed Citation Articles by Rao, G. N. Articles by Buckley, L. A.

Carcinogenicity of 2',3'-Dideoxycytidine in Mice

National Institute of Environmental Health Sciences [G. N. R., B. J. C., J. F. F.] and Research Triangle Institute [L. A. B.], Research Triangle Park, North Carolina 27709, and Southern Research Institute, Birmingham, Alabama 35205 [H. D. G., J. E. H., R. D. M.]

2',3'-dideoxycytidine (ddC) is a synthetic pyrimidine nucleoside analogue approved for treatment of HIV-positive patients. Previous studies indicated that ddC has the potential to cause thymic lymphoma in C57BL/6 x C3H F₁ (hereafter called B6C3F₁) mice. In this study, we evaluated the carcinogenic potential of ddC in two different mouse models. B6C3F₁ hybrid mice carry ecotropic endogenous proviral sequences that may be activated to cause lymphoma, whereas NIH Swiss mice lack proviral sequences that can be expressed. The mice were treated with ddC by gavage at 500 and 1000 mg/kg/day for up to 6 months (human dose, 2.25 mg/day) and evaluated for toxicity, plasma levels of ddC, and pathological changes. Lymphocyte cell markers from the thymic lymphomas were assessed by immunophenotyping. Expression of p53 protein was evaluated using immunohistochemical staining. Treatment-related thymic lymphomas were present in both mouse models with a higher incidence in NIH Swiss than in B6C3F₁ mice. The lymphomas were more prevalent in females than in males of both mouse models. Most mice with thymic lymphoma died during the course of the study. In addition to the thymus, lymphoma was often present in lymph nodes, spleen, and other organs. Lymphomas arose more frequently in mice that lack endogenous ecotropic retroviral sequences and thus were not due to activation of endogenous provirus. During the third month of the study, a few NIH Swiss mice that died had granulosa cell tumors of the ovary. Treatment-related but reversible thymic atrophy was observed in both mouse models. There was a very high correlation between the internal dose of ddC and the incidence of thymic lymphoma in both mouse models. Most of the lymphocytes from control thymuses and ddC-induced lymphomas were positive for Thy-1.2 (pan-T), heat stable antigen, and CD4 and CD8 markers, with no marked differences in the lymphocyte markers of the tumors between sexes or dose groups. p53 protein was detected in only 20% (23/115) of the ddC-induced lymphomas with mostly minimal expression in scattered cells. Because ddC induced lymphomas in two different mouse models, the potential carcinogenic risk should be considered in long-term treatment of HIV-positive patients, especially children and adolescent patients treated with ddC.

¹ To whom requests for reprints should be addressed, at National Institute of Environmental Health Sciences, MD B3-08, P. O. Box 12233, Research Triangle Park, NC 27709. Phone: (919) 541-7899; Fax: (919) 541-4714.

Received 5/14/96. Accepted 8/15/96.

This article has been cited by other articles:

				L. Lambertini, K. Surin, T.-V. T. Ton, N. Clayton, J. K. Dunnick, Y. Kim, H.-H. L. Hong, T. R. Devereux, and R. C. Sills Analysis of p53 Tumor Suppressor Gene, H-ras Protooncogene and Proliferating Cell Nuclear Antigen (PCNA) in Squamous Cell Carcinomas of HRA/Skh Mice Following Exposure to 8-Methoxypsoralen (8-MOP) and UVA Radiation (PUVA Therapy) Toxicol Pathol, February 1, 2005; 33(2): 292 - 299. [Abstract] [Full Text] [PDF]

				H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF]